The Use of Routinely Collected Data for Interventional Research in Secondary Care: A feasibility evaluation of a multi-centre ra
![CambridgeATS on Twitter: "Next G2T webinar on 8 September, 4pm BST! Dr Tom Oakley, VP of EU Regulatory at ProPharma Group, will talk about the role of regulators in developing new medicines. CambridgeATS on Twitter: "Next G2T webinar on 8 September, 4pm BST! Dr Tom Oakley, VP of EU Regulatory at ProPharma Group, will talk about the role of regulators in developing new medicines.](https://pbs.twimg.com/media/E-R2-DiXoAImpYQ.jpg)
CambridgeATS on Twitter: "Next G2T webinar on 8 September, 4pm BST! Dr Tom Oakley, VP of EU Regulatory at ProPharma Group, will talk about the role of regulators in developing new medicines.
![Avoiding waste in research: the role of public involvement Iain Chalmers Coordinator, James Lind Initiative 'Putting people first in research' INVOLVE. - ppt download Avoiding waste in research: the role of public involvement Iain Chalmers Coordinator, James Lind Initiative 'Putting people first in research' INVOLVE. - ppt download](https://images.slideplayer.com/13/4061377/slides/slide_14.jpg)
Avoiding waste in research: the role of public involvement Iain Chalmers Coordinator, James Lind Initiative 'Putting people first in research' INVOLVE. - ppt download
![Accessing routinely collected health data to improve clinical trials: recent experience of access | Trials | Full Text Accessing routinely collected health data to improve clinical trials: recent experience of access | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-021-05295-5/MediaObjects/13063_2021_5295_Fig3_HTML.png)